BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, June 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 4, 2012
View Archived Issues
U.S. and Australian group prepares new anticancer compounds
Read More
New anticancer agents synthesized
Read More
Common polymorphism linked to atherosclerosis
Read More
Australian study unveils new possible atherosclerosis marker in diabetes
Read More
Gene-modified cells are chemoprotective in phase I/II glioblastoma trial
Read More
Swiss company presents new neurotrypsin inhibitors
Read More
Merck KGaA divulges novel anticancer compounds
Read More
Novel serotonin 5-HT6 receptor ligands reported by Abbott
Read More
Novel FLAP inhibitors patented by Boehringer Ingelheim
Read More
Roche group identifies new cathepsin inhibitors
Read More
NIH awards grant to researchers developing new TB vaccine
Read More
Ongoing ASCO meeting features first clinical data on multikinase inhibitor
Read More
Cancer Research UK program aids trials of targeted cancer treatments
Read More
RaQualia begins first-in-human study of RQ-00000010
Read More
Mitsubishi Tanabe terminates license agreement
Read More
Cell Therapeutics completes acquisition of S*BIO product
Read More
CSL Behring submits application for Privigen
Read More
NicOx announces board's decision on remaining Altacor equity
Read More
Novartis ALK inhibitor for cancer shows promise in first-in-human trial
Read More
EpiCept receives EMA scientific advice for CIPN program
Read More
Auxilium planning sBLA for Xiaflex in new indication
Read More
Lilly launches radioactive diagnostic in select U.S. markets
Read More
Orexo and ProStrakan reconfigure worldwide rights to cancer pain product
Read More
Stiefel to acquire rights to investigational drug for psoriasis and atopic dermatitis
Read More
Forest Laboratories and Nabriva to collaborate on development of antibacterial agent
Read More
